Century Therapeutics, Inc. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/398e4ff5-81d7-45bb-8ecf-a151077c8288/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-17.3M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-026759 |
| FY 2024 | $-138.1M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003299 |
| FY 2023 | $-146.5M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003165 |
| FY 2022 | $-133.8M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003962 |
| FY 2021 | $-94.9M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-003867 |
| FY 2020 | $-53.9M | 2020-01-01 – 2020-12-31 | evidence 0001558370-22-003867 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Century Therapeutics, Inc. — all facts · Revenue · Net Income